UNSPSC 51286206: Fosfomycin trometamol

This classification denotes a urinary anti-infective agent with the molecular formula C4H11NO3.C3H7O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7FXW6U30GY, chemically known as phosphonic acid, (3-methyloxiranyl)-, (2r-cis)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) but more generally known as fosfomycin trometamol, which bears US NIH Compound Identifier 54331. European Medicines Agency schedules Fosfomycin trometamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02263MIG.

Most nations schedule fosfomycin trometamol under HS 29419000. SMILES: C[C@H]1[C@H](O1)P(=O)(O)O.C(C(CO)(CO)N)O.

UNSPSC 51286206 Fosfomycin trometamol is a Commodity code nominally naming a specific antibiotic pharmaceutical product, but recent state and local solicitations tagged with this code show substantial mismatch between the nominal scope and actual procurement activity. The opportunities posted under this code span naloxone and drug deactivation systems, first-aid and rescue medical supplies, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer pharmacy benefit programs—none of which are fosfomycin trometamol. This code sees minimal relevant recent activity; the four opportunities in the record are plainly unrelated to the product name and appear to reflect tagging errors or misalignment between the procurement system and the actual goods or services being bought.

The issuing bodies span county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission, Minnesota Department of Administration), and municipal fire departments (City of Tampa). Geographic spread includes Florida, Texas, and Minnesota, with one multi-state cooperative purchasing vehicle (MMCAP) serving participating states and Oregon. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first-aid supplies (due March 13, 2026, with an estimated contract value of $700,000.00 and SLBE set-asides), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The code shows little actionable signal for vendors in the fosfomycin market and warrants verification of the correct UNSPSC classification before pursuing opportunities.